Insider Buy/Sell Details for the Healthcare Sector — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1586)
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
2,373
Price
$276.17
Total Value
$655.34K
Shares Held After
73,293
% of Holdings
3.1%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
9,430
Price
$275.45
Total Value
$2.60M
Shares Held After
75,666
% of Holdings
11.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bozic Carmen — EVP and CMO
Shares
2,329
Price
$480.31
Total Value
$1.12M
Shares Held After
37,734
% of Holdings
5.8%
JOHNSON & JOHNSON (JNJ)
Decker Robert J — VP Corporate Controller
Shares
4,075
Price
$247.87
Total Value
$1.01M
Shares Held After
23,682
% of Holdings
14.7%
NovoCure Limited (NVCR)
Weinberg Uri — Chf Medical and Innovation Ofr
Shares
7,461
Price
$13.84
Total Value
$103.26K
Shares Held After
213,757
% of Holdings
3.4%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
1,600
Price
$14.38
Total Value
$23.01K
Shares Held After
11,845,939
% of Holdings
0.0%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
214,839
Price
$14.12
Total Value
$3.03M
Shares Held After
11,844,339
% of Holdings
1.8%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
300,000
Price
$13.90
Total Value
$4.17M
Shares Held After
11,629,500
% of Holdings
2.6%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: EVP, Chief Legal Officer
Shares
3,325
Price
$27.95
Total Value
$92.93K
Shares Held After
143,678
% of Holdings
2.3%
NovoCure Limited (NVCR)
Puri Michal Nath — Chief Human Resources Officer
Shares
1,441
Price
$13.66
Total Value
$19.69K
Shares Held After
162,322
% of Holdings
0.9%
Adaptive Biotechnologies Corp (ADPT)
ROBINS CHAD M — Director
Shares
182,891
Price
$15.99
Total Value
$2.92M
Shares Held After
2,276,354
% of Holdings
7.4%
Cardinal Health, Inc. (CAH)
Greene Michelle D. — Chief Information Officer
Shares
2,646
Price
$228.47
Total Value
$604.53K
Shares Held After
12,230
% of Holdings
17.8%
Cardinal Health, Inc. (CAH)
Greene Michelle D. — Chief Information Officer
Shares
100
Price
$228.55
Total Value
$22.86K
Shares Held After
14,876
% of Holdings
0.7%
Option Care Health, Inc. (OPCH)
Bavaro Michael — Chief Human Resources Officer
Shares
6,000
Price
$33.00
Total Value
$198.00K
Shares Held After
33,249
% of Holdings
15.3%
Option Care Health, Inc. (OPCH)
Pate R Carter — Director
Shares
30,287
Price
$32.05
Total Value
$970.62K
Shares Held After
11,623
% of Holdings
72.3%
NovoCure Limited (NVCR)
Paravasthu Mukund — Chief Operating Officer
Shares
1,555
Price
$13.66
Total Value
$21.25K
Shares Held After
76,751
% of Holdings
2.0%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
3,761
Price
$45.72
Total Value
$171.97K
Shares Held After
10,503
% of Holdings
26.4%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
3,739
Price
$45.13
Total Value
$168.76K
Shares Held After
14,264
% of Holdings
20.8%
HARROW, INC. (HROW)
Opaleye Management Inc. — 10% Owner
Shares
5,000
Price
$54.18
Total Value
$270.90K
Shares Held After
65,000
% of Holdings
7.1%
NovoCure Limited (NVCR)
Leonard Frank X — Chief Executive Officer
Shares
9,734
Price
$13.66
Total Value
$133.00K
Shares Held After
338,011
% of Holdings
2.8%
Bausch & Lomb Corp (BLCO)
VON ESCHENBACH ANDREW C. — Director
Shares
4,364
Price
$18.30
Total Value
$79.88K
Shares Held After
66,450
% of Holdings
6.6%
NovoCure Limited (NVCR)
Leupin Nicolas — Former Chief Medical Officer
Shares
1,029
Price
$13.66
Total Value
$14.06K
Shares Held After
104,079
% of Holdings
1.0%
ZIVO Bioscience, Inc. (ZIVO)
YALDOO LAITH L — Director
Shares
1,543
Price
$9.72
Total Value
$15.00K
Shares Held After
583,615
% of Holdings
0.3%
AdaptHealth Corp. (AHCO)
WOLF DALE B — Director
Shares
8,000
Price
$8.96
Total Value
$71.68K
Shares Held After
104,235
% of Holdings
7.7%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
1,725
Price
$496.95
Total Value
$857.24K
Shares Held After
98,278
% of Holdings
1.7%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
5,995
Price
$496.16
Total Value
$2.97M
Shares Held After
100,003
% of Holdings
5.7%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
15,580
Price
$495.38
Total Value
$7.72M
Shares Held After
105,998
% of Holdings
12.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
3,498
Price
$494.33
Total Value
$1.73M
Shares Held After
121,578
% of Holdings
2.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
2,520
Price
$493.29
Total Value
$1.24M
Shares Held After
125,076
% of Holdings
2.0%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
949
Price
$491.30
Total Value
$466.24K
Shares Held After
127,596
% of Holdings
0.7%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
2,725
Price
$490.54
Total Value
$1.34M
Shares Held After
128,545
% of Holdings
2.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
460
Price
$489.32
Total Value
$225.09K
Shares Held After
131,270
% of Holdings
0.3%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
3,278
Price
$488.27
Total Value
$1.60M
Shares Held After
131,730
% of Holdings
2.4%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
2,510
Price
$487.13
Total Value
$1.22M
Shares Held After
135,008
% of Holdings
1.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
240
Price
$482.84
Total Value
$115.88K
Shares Held After
137,518
% of Holdings
0.2%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
120
Price
$481.50
Total Value
$57.78K
Shares Held After
137,758
% of Holdings
0.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
400
Price
$479.75
Total Value
$191.90K
Shares Held After
137,878
% of Holdings
0.3%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
400
Price
$10.86
Total Value
$4.34K
Shares Held After
22,006
% of Holdings
1.8%
Absci Corp (ABSI)
Pangalos Menelas N — Director
Shares
75,095
Price
$2.74
Total Value
$205.76K
Shares Held After
189,055
% of Holdings
39.7%
BridgeBio Pharma, Inc. (BBIO)
Valantine Hannah — Director
Shares
10,900
Price
$67.84
Total Value
$739.50K
Shares Held After
7,465
% of Holdings
59.4%
BridgeBio Pharma, Inc. (BBIO)
Valantine Hannah — Director
Shares
14,584
Price
$67.08
Total Value
$978.28K
Shares Held After
18,365
% of Holdings
44.3%
INTUITIVE SURGICAL INC (ISRG)
Widman Fredrik — VP Corporate Controller
Shares
249
Price
$499.71
Total Value
$124.43K
Shares Held After
909
% of Holdings
21.5%
Edesa Biotech, Inc. (EDSA)
Nijhawan Pardeep — Director
Shares
30,000
Price
$2.22
Total Value
$66.70K
Shares Held After
371,702
% of Holdings
8.1%
Jazz Pharmaceuticals plc (JAZZ)
Carr Patricia — SVP, Chief Accounting Officer
Shares
1,117
Price
$190.91
Total Value
$213.24K
Shares Held After
9,235
% of Holdings
10.8%
GILEAD SCIENCES, INC. (GILD)
O'Day Daniel Patrick — Director
Shares
100
Price
$145.71
Total Value
$14.57K
Shares Held After
642,308
% of Holdings
0.0%
GILEAD SCIENCES, INC. (GILD)
O'Day Daniel Patrick — Director
Shares
6,419
Price
$145.18
Total Value
$931.90K
Shares Held After
642,408
% of Holdings
1.0%
GILEAD SCIENCES, INC. (GILD)
O'Day Daniel Patrick — Director
Shares
3,481
Price
$144.04
Total Value
$501.39K
Shares Held After
648,827
% of Holdings
0.5%
Claritev Corp (CTEV)
Kim Michael — EVP, Chief Digital Officer
Shares
30,000
Price
$14.30
Total Value
$428.95K
Shares Held After
137,973
% of Holdings
21.7%
Claritev Corp (CTEV)
Dalton Travis — Director
Shares
15,380
Price
$13.00
Total Value
$199.93K
Shares Held After
24,952
% of Holdings
61.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
140
Price
$334.39
Total Value
$46.81K
Shares Held After
22,129
% of Holdings
0.6%
Showing 1–50 of 1586 transactions (page 1 of 32)